World's leading clinical conference on bone, joint and muscle health
Programme Sponsored sessions
Thursday May 4th - CEST Time zone
19:00 - 20:00
Available Industry Sponsored Welcome Cocktail
Friday May 5th - CEST Time zone
08:00 - 09:00
Available Sponsored Breakfast Satellite Symposium
08:00 - 09:00
AgNovos Healthcare Breakfast Satellite Symposium
12:15 - 13:45
UCB Sponsored Lunch Satellite Symposium - The fast path in osteoporosis treatment: Correcting the course
Chairpersons :
Maria Luisa Brandi
& Laia Gifre
- Welcome and introduction
- Bone-forming agents first: Embracing change in the treatment paradigm
- Romosozumab first for patients at very high risk of fracture: Standing out from the crowd
- Romosozumab first in practice: Clinical conundrums
- Q&A/discussion
- Conclusions and closing remarks
12:15 - 13:45
Sponsored Lunch Satellite Symposium
14:00 - 15:00
Room 123
IBSA Sponsored Meet-The-Expert Session - The economic burden of OA and the importance of cost-effective Treatments
Chairperson :
Olivier Bruyère
- How can Health Economics help to optimize patient care in OA
- An example of Health Economics evaluation: The case of I.A. HL-HA formulation
- Q&A session
17:00 - 18:30
Available Sponsored Satellite Symposium
17:00 - 18:30
Available Sponsored Satellite Symposium
Saturday May 6th - CEST Time zone
08:00 - 09:00
Auditorium B
Sponsored Breakfast Satellite Symposium - Bone status assessment with REMS: an update on fracture risk prediction
Chairperson :
Giuseppe Guglielmi
- Introduction
- Fracture risk assessment by REMS in primary and secondary osteoporosis
- REMS for the evaluation of bone Quantity and Quality
- Precision. Repeatability and Diagnostic Accuracy of REMS technology
- REMS employment in clinical routine: the Polish experience
- Take Home Message
12:15 - 13:45
Sponsored Lunch Satellite Symposium
12:15 - 13:45
AMGEN Sponsored Satellite Symposium - Addressing a data gap in osteoporosis: comparing clinical effectiveness of bisphosphonates and denosumab
Chairperson :
Xavier Nogues
- Chair's Welcome
- Non-vertebral non-hip fractures; have we under-recognized their burden?
- Short or long-term denosumab therapy to optimize fracture risk reduction
- Clinical effectiveness of anti-resorptives for fracture risk reduction using the Medicare database
- Panel discussion
17:00 - 18:30
Available Sponsored Satellite Symposium
17:00 - 18:30
Available Sponsored Satellite Symposium
Sunday May 7th - CEST Time zone
09:00 - 10:00
UCB Sponsored Meet-The-Expert Session - Identifying very high fracture risk patients in real-world clinical practice: Innovations and implications
Chairperson/speaker :
Maria Talla
- Current post-fracture care pathway at NHS Greater Glasgow and Clyde (NHSGCC)
- Optimising identification of very high fracture risk patients in the clinic
- Innovations in fracture-risk evaluation